FAKTOR-OPTIONSSCHEIN - NOVO-NORDISK B | Market Closed - Börse Stuttgart 11:51:05 2024-05-22 EDT | ||
| 0.088 EUR | -5.38% |
|
| Current month | -20.00% | ||
| 1 month | -28.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 0.088 | -5.38% |
| 24-05-21 | 0.093 | 0.00% |
| 24-05-20 | 0.093 | -8.82% |
| 24-05-17 | 0.102 | +6.25% |
| 24-05-16 | 0.096 | +6.67% |
Delayed Quote Börse Stuttgart
Last update May 22, 2024 at 11:51 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | MB50TE |
| ISIN | DE000MB50TE5 |
| Date issued | 2023-03-30 |
| Strike | 1,113 kr |
| Maturity | Unlimited |
| Parity | 282.76 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.21 € |
|---|---|
| Lowest since issue | 0.088 € |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
923
DKK
Average target price
909.2
DKK
Spread / Average Target
-1.49%
- Stock Market
- Certificates
- Certificat
